Biasing Gβγ Downstream Signaling with Gallein Inhibits Development of Morphine Tolerance and Potentiates Morphine-Induced Nociception in a Tolerant State
Molecular Pharmacology · 2024-07 · 106 (1) · 47-55
DOI: 10.1124/molpharm.124.000875 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Pharmacology, 2024-07. Verfasst von Gissell A Sanchez und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, University of Michigan, Ann Arbor, Michigan. Hauptthemen laut MEDLINE: Morphine, Drug Tolerance, Signal Transduction, GTP-Binding Protein beta Subunits. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDA NIH HHS.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology, University of Michigan, Ann Arbor, Michigan.
- Department of Pharmacology, University of Michigan, Ann Arbor, Michigan ejutkiew@umich.edu avsmrcka@umich.edu.
Förderung
- NIDA NIH HHS
Zitieren
APA
Sanchez, G. A., Smrcka, A. V., & Jutkiewicz, E. M. (2024). Biasing Gβγ Downstream Signaling with Gallein Inhibits Development of Morphine Tolerance and Potentiates Morphine-Induced Nociception in a Tolerant State. Molecular Pharmacology, 106(1), 47-55. https://doi.org/10.1124/molpharm.124.000875
Vancouver
Sanchez GA, Smrcka AV, Jutkiewicz EM. Biasing Gβγ Downstream Signaling with Gallein Inhibits Development of Morphine Tolerance and Potentiates Morphine-Induced Nociception in a Tolerant State. Molecular Pharmacology. 2024;106(1):47-55. doi:10.1124/molpharm.124.000875
BibTeX
@article{Sanchez2024,
author = {Sanchez, Gissell A and Smrcka, Alan V and Jutkiewicz, Emily M},
title = {Biasing Gβγ Downstream Signaling with Gallein Inhibits Development of Morphine Tolerance and Potentiates Morphine-Induced Nociception in a Tolerant State},
journal = {Molecular Pharmacology},
year = {2024},
volume = {106},
number = {1},
pages = {47--55},
doi = {10.1124/molpharm.124.000875}
}
EUVIMED